Trump MFN drug pricing policy seen reshaping pharma investment flows
President Donald Trump’s “most-favoured nation” drug pricing policy may boost affordability, with the biggest impact potentially shifting global pharma investment flows.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
President Donald Trump’s “most-favoured nation” drug pricing policy may boost affordability, with the biggest impact potentially shifting global pharma investment flows.